Roy Jakobs, CEO of Royal Philips: “We delivered a good start to 2026, with strong order intake growth at 6%, comparable sales growth of 4% and margin expansion of 40 basis points, reflecting ...

Louvain-la-Neuve, Belgium, 06 May 2026 – (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and a global provider of dosimetry and quality assurance (QA) ...

Q1 2026 adjusted operating profit decreased by 6% at CER, while reported operating profit increased by 65% at CER, driven by a provision reversal related to the 340B Drug Pricing Program in the US.

Avalo intends to use the net proceeds from the offering, together with its existing cash, cash equivalents and short-term investments, to advance the clinical development of abdakibart, including ...

WriteUpp, the practice management platform serving clinicians across the UK, Ireland, and Canada, has introduced AI Medical Scribe, a monthly per-user add-on that generates structured clinical notes ...

(“Dianthus”; NASDAQ: DNTH), has selected Sjögren's disease (SjD), systemic lupus erythematosus (SLE), and dermatomyositis (DM) as the first three priority indications for clinical development of ...

Leerink Partners, TD Cowen and Evercore ISI acted as joint bookrunning managers for the offering. LifeSci Capital also acted as a bookrunning manager in the offering. Citizens Capital Markets acted as ...

Available 24/7, the IR system supports multi-language interaction, allowing investors across regions to engage in their preferred language. Users can explore information and ask questions in a private ...

Longeveron Inc. (NASDAQ: LGVN), a clinical stage biotechnology company developing cellular therapy for life-threatening, rare pediatric and ...

EPIK is working with Casimir Jones, S.C., a premier life sciences intellectual property firm and recognized leader in psychedelic patent law, to advise the Company on its patent strategy and support ...

Title: Menin Inhibitor Icovamenib Activates Mechanisms That Support Metabolic Health Session: Late-Breaking Poster Session 2871-LB Presenter: Mini Balakrishnan, Ph.D. Date/Time: June 7, 2026, at 12:30 ...

The complete text of the letter being mailed to stockholders follows: We are reaching out to you directly because your vote at our upcoming 2026 Annual Meeting (the “Annual Meeting”) on June 9, 2026 ...